AU · Healthcare

RHYTHM Biosciences Ltd (RHY)

Diagnostics & Research

RHYTHM Biosciences Ltd (RHY) is listed on AU in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RHY

P/E ratio

18.00

RHYTHM Biosciences Ltd (RHY) — FAQ

What is RHY's P/E ratio?

The price-to-earnings (P/E) ratio for RHYTHM Biosciences Ltd (RHY) is 18.00 (data as of 2026-05-24).

Does RHYTHM Biosciences Ltd pay a dividend?

Dividend yield is not available in the current snapshot for RHYTHM Biosciences Ltd (RHY). Check the MyAverix Finance app for the latest dividend data.

What sector is RHYTHM Biosciences Ltd in?

RHYTHM Biosciences Ltd (RHY) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is RHY listed on?

RHY is listed on AU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)